Protopapas Anna
Insider CIK 1347582 · DRNA Director · MRSN President and CEO, Director · BIVV Director · NUVL Director · ARIA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 40,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-15 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-15 | 3,444 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2026-06-16 | 2026-06-18 | 3,444 | — | $0 | 8,590 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 5,227 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,131 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,200 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 11,250 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 9,043 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 665 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 11,761 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 988 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 18 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 166 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 8,137 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 542 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 7,519 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 480 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,500 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,460 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 2,890 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 6,721 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 9,609 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 4,147 | — | $0 | 4,147 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2025-06-18 | 2025-06-20 | 2,647 | — | $0 | 5,146 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 61,500 | — | $0 | 61,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-16 | 2025-01-17 | 8,637 | $0.58 | $5.0K | 168,041 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-15 | 2025-01-17 | 21,250 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-15 | 2025-01-16 | 6,191 | $0.63 | $3.9K | 155,428 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-15 | 2025-01-17 | 21,250 | — | $0 | 176,678 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-14 | 2025-01-16 | 16,750 | — | $0 | 16,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-14 | 2025-01-15 | 11,534 | $0.66 | $7.6K | 144,869 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-14 | 2025-01-16 | 16,750 | — | $0 | 161,619 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-13 | 2025-01-15 | 31,250 | — | $0 | 62,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-13 | 2025-01-15 | 31,250 | — | $0 | 156,403 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 3,789 | — | $0 | 3,789 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2024-06-12 | 2024-06-14 | 2,499 | — | $0 | 2,499 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-17 | 29,399 | $2.71 | $79.7K | 125,153 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-15 | 2024-01-17 | 21,250 | — | $0 | 21,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-15 | 2024-01-17 | 17,708 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-15 | 2024-01-17 | 21,250 | — | $0 | 136,844 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-15 | 2024-01-17 | 17,708 | — | $0 | 154,552 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-14 | 2024-01-17 | 16,750 | — | $0 | 33,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-14 | 2024-01-17 | 16,750 | — | $0 | 115,594 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-13 | 2024-01-17 | 31,250 | — | $0 | 93,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-13 | 2024-01-17 | 31,250 | — | $0 | 98,844 | SEC↗ |
| NUVL Nuvalent, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-20 | 5,000 | — | $0 | 15,000 | SEC↗ |
| NUVL Nuvalent, Inc. | M Exercise | 2023-12-18 | 2023-12-20 | 5,000 | $9.36 | $46.8K | 5,000 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 5,000 | $75.67 | $378.4K | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-09-11 | 2023-09-13 | 16,643 | — | $0 | 16,643 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-09-11 | 2023-09-13 | 16,643 | — | $0 | 67,594 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2023-01-17 | 2023-01-18 | 17,346 | $5.74 | $99.6K | 48,733 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-15 | 2023-01-18 | 21,250 | — | $0 | 42,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-15 | 2023-01-18 | 17,708 | — | $0 | 17,708 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-15 | 2023-01-18 | 17,708 | — | $0 | 66,079 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-15 | 2023-01-18 | 21,250 | — | $0 | 48,371 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-14 | 2023-01-18 | 16,750 | — | $0 | 50,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-14 | 2023-01-18 | 16,750 | — | $0 | 27,121 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 562,500 | — | $0 | 562,500 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | G Gift | 2022-05-20 | 2023-01-18 | 240,244 | — | $0 | 240,244 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | G Gift | 2022-05-20 | 2023-01-18 | 240,244 | — | $0 | 10,371 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2022-03-30 | 2022-03-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 67,000 | — | $0 | 67,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-19 | 21,250 | — | $0 | 63,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-19 | 17,708 | — | $0 | 35,416 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 301,450 | — | $0 | 301,450 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2022-01-14 | 2022-01-19 | 38,958 | — | $0 | 322,878 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2021-07-19 | 2021-07-19 | 21,901 | $12.02 | $263.3K | 282,978 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2021-07-16 | 2021-07-19 | 20,043 | $12.47 | $249.9K | 304,879 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2021-07-15 | 2021-07-19 | 100,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2021-07-15 | 2021-07-19 | 100,000 | — | $0 | 324,922 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 85,000 | — | $0 | 85,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 382,500 | — | $0 | 382,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-20 | 17,709 | — | $0 | 53,124 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2021-01-15 | 2021-01-20 | 17,709 | — | $0 | 230,120 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | F Tax w/h | 2021-01-15 | 2021-01-20 | 5,198 | $21.09 | $109.6K | 224,922 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 3,333 | — | $0 | 3,333 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-15 | 2020-01-16 | 318,750 | — | $0 | 318,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-15 | 2020-01-16 | 70,833 | — | $0 | 70,833 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-07-17 | 2019-07-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-06-20 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-01-23 | 2019-01-25 | 217,500 | — | $0 | 217,500 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-01-23 | 2019-01-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 5,455 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 23,006 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer | 2018-03-08 | 2018-03-08 | 1,056 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-02-02 | 2018-02-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2018-01-31 | 2018-02-02 | 5,455 | — | $0 | 5,455 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2017-12-20 | 2017-12-21 | 10,417 | — | $0 | 748,366 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2017-12-20 | 2017-12-21 | 10,417 | $1.53 | $15.9K | 130,719 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 325,189 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion | 2017-07-03 | 2017-07-06 | 72,263 | — | $0 | 192,565 | SEC↗ |
| BIVV Bioverativ Inc. | A Award | 2017-04-17 | 2017-04-17 | 1,056 | $56.83 | $60.0K | 1,056 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-28 | 2017-03-02 | 23,006 | $52.08 | $1.20M | 23,006 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 75,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer | 2017-02-16 | 2017-02-16 | 41,910 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 29,410 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 41,910 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award | 2016-02-01 | 2016-02-03 | 23,902 | — | $0 | 23,902 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2015-04-28 | 2015-04-30 | 75,000 | — | $0 | 75,000 | SEC↗ |